Keywords
Atrial fibrillation
Risk factors
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the relationship between the diagnosis of Atrial Fibrillation and the occurrence of Stroke, in addition to its clinical repercussions, in order to add scientific knowledge on the subject addressed. Methods: The present study is an integrative literature review based on scientific evidence, whose production was based on: recognition of a relevant topic, choice of the question to be addressed, search for articles in digital databases, establishment of inclusion and exclusion criteria, and subsequent reading and discussion of the results found. Results: Atrial Fibrillation is directly related to the occurrence of thromboembolic phenomena, and the recognition of risk factors is essential for understanding and preventing this association. The importance of using anticoagulants to reduce the risk of stroke in patients diagnosed with AF was also observed. Final considerations: It is considered that screening and prevention are the two most relevant points in the search for a better prognosis. In addition, the need for greater updating of health professionals in relation to these new drugs and their prescription was observed.
References
CAMPBELL BCV, et al. Ischaemic stroke. Nature Reviews Disease Primers, 2019; 5(1).
CINTRA FD e FIGUEIREDO MJO. Fibrilação Atrial (Parte 1): Fisiopatologia, Fatores de Risco e Bases Terapêuticas. Arquivos Brasileiros de Cardiologia, 2021; 116(1): 129-139.
DE SOUSA CM, et al. FIBRILAÇÃO ATRIAL E DEMÊNCIA VASCULAR: UMA REVISÃO INTEGRATIVA DA LITERATURA. Revista Contemporânea, 2022; 2(3): 739-759.
DUBNER S, et al. Stroke Prevention in Atrial Fibrillation. Findings from the GLORIA-AF Registry. Revista Argentina de Cardiologia, 2020; 88(4): 282-288.
FRANZOI AEA, et al. Uso de anticoagulantes em pacientes com fibrilação atrial em primeiro evento de avc e em recidivas. Arquivos Catarinenses de Medicina, 2018; 47(4): 53–63.
FREITAS EL, et al. Episódios de Alta Frequência Atrial e sua Associação com Eventos Isquêmicos Cerebrais em Pacientes Chagásicos. Arquivos Brasileiros de Cardiologia, 2020; 115(6): 1072-1079.
GÜNDÜZ ZB, et al. Scanning of paroxysmal atrial fibrillation as an etiological risk factor in patients with acute ischemic stroke: prospective study. Sao Paulo Medical Journal, 2022; 140(2): 182-187.
GUO J, et al. Racial And Urban-rural Disparities In The Frequency Of Ischemic Stroke As First Manifestation Of Atrial Fibrillation Circulation, 2021; 143(9).
HAJJ M, et al. Evaluation of risk factors and drug adherence in the occurrence of stroke in patients with atrial fibrillation. Pharmacy Practice, 2020; 18(2): 1860.
HALIMA MB, et al. Silent stroke in patients with atrial fibrillation: Prevalence and predictive factors. Tunis Med, 2021; 99(4): 416-422.
HENZ BD e LEITE LR. Fibrilação Atrial e Eventos Tromboembólicos Criptogêncios. Arq. Bras. Cardiol., São Paulo, 2018; 111(2): 132-133.
ITAQUY RB, et al. Disfagia e acidente vascular cerebral: relação entre o grau de severidade e o nível de comprometimento neurológico. J da Sociedade Brasileira de Fonoaudiologia, 2011; 23(4): 385-389.
JUSTO FA e SILVA AFG. Aspectos epidemiológicos da fibrilação atrial. Revista de Medicina, 2014; 93(1): 1.
KORNEJ J, et al. Epidemiology of Atrial Fibrillation in the 21st Century. Circulation Research, 2020; 127(1): 4-20.
LEITE BC, et al. UM ESTUDO DA FIBRILAÇÃO ATRIAL SOB UMA PERSPECTIVA EPIDEMIOLÓGICA ATRELADA AOS FATORES DE RISCO ENVOLVIDOS – UMA REVISÃO. Journal of Education Science and Health, 2022; 2(1).
MAGALHÃES LP, et al. II Diretrizes Brasileiras de Fibrilação Atrial. Arquivos Brasileiros de Cardiologia, 2016; 106(4).
MELO LS, et al. Acidente vascular cerebral: achados clínicos e principais complicações. Revista Brasileira Ciências da Saúde - USCS, 2016; 14(48).
MWLIA F, et al. Prevalence and predictors of atrial fibrillation in patients with embolic stroke of undetermined source: a real-life single-center retrospective study. Neurol Sci, 2021; 42(9): 3707–3714.
NIAZ S, et al. Anticoagulation for newly diagnosed atrial fibrillation and 90-day rates of stroke and bleeding. Canadian Journal of Emergency Medicine, 2021; 23(30): 325-329.
PENÃ M, et al. Fibrilación auricular en pacientes con ictus isquémico en Hospital Universitario Comandante Faustino Pérez. 2017. Rev. medica electron, 2018; 40(2): 360-370.
RAHMAN F, et al. Global epidemiology of atrial fibrillation. Nature Reviews Cardiology, 2014; 11(11): 639-654.
RANDOLPH SA. Ischemic Stroke. Workplace Health & Safety, 2016; 64(9): 444.
SCAVASINE CV, et al. Embolic Stroke of Undetermined Source (ESUS) and Stroke in Atrial Fibrillation Patients: not so Different after all? Int. J. Cardiovasc. Sci., 2021; 34(5): 517-522.
SUN Y, et al. Effect of Tirofiban on new cerebral microbleeds after mechanical thrombectomy in patients with acute ischemic stroke. Revista da Associação Médica Brasileira, 2021; 67(11): 1564-1569.
ZEITLER EP e PICCINI JP. Pre-Diabetes and Stroke in Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 2021; 77(7): 885-887.
ZIMETBAUM P. Atrial Fibrillation. Annals of Internal Medicine, 2017; 166(5): ITC33-ITC48.